AXIAL Logo 2021MAR05.png
Axial Therapeutics to Present at BioJapan Conference
06 oct. 2022 08h00 HE | Axial Therapeutics
WOBURN, Mass., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Axial Therapeutics Inc., a clinical-stage biopharmaceutical company dedicated to the development of gut-targeted, small molecule therapeutics for...
22157.jpg
Microbiome Therapeutics Global Market Report 2022: Increasing R&D By Major Players Creates Lucrative Opportunities
04 oct. 2022 05h13 HE | Research and Markets
Dublin, Oct. 04, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Therapeutics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global microbiome therapeutics...
Global Microbiome Therapeutics Market
Microbiome Therapeutics Market Report 2022: Success Rate in C. Difficile Infection Driving Adoption
19 sept. 2022 07h38 HE | Research and Markets
Dublin, Sept. 19, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Therapeutics Market Size, Share & Trends Analysis Report by Type (FMT, Microbiome Drugs), by Application (C. difficile, Crohn's...
Global Microbiome Sequencing Services Market
Global Microbiome Sequencing Services Market Report 2022: Demand for Early Disease Detection and Diagnosis Fuels 20.09% Annual Growth
12 sept. 2022 08h43 HE | Research and Markets
Dublin, Sept. 12, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Sequencing Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Global Microbiome Market
Microbiome Global Market Report 2022: Increased Need for Immunology, Increasing Collaborations, Government Initiatives, Increased Healthcare Expenditure All Driving Growth
06 sept. 2022 04h53 HE | Research and Markets
Dublin, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's offering.The global microbiome...
Global Microbiome Market
Microbiome Global Market Report 2022: Increasing Prevalence of Inflammatory Bowel Disease Fueling Sector Growth
31 août 2022 04h33 HE | Research and Markets
Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Global Market Report 2022, Type, Application, Technology" report has been added to ResearchAndMarkets.com's offering. The global...
22157.jpg
Microbiome Partnering Terms and Agreements Report 2022: The Leading & Most Active Microbiome Dealmakers Since 2010
18 août 2022 06h43 HE | Research and Markets
Dublin, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The "Global Microbiome Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering. The Global Microbiome...
Untitled-1
Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics
15 août 2022 23h41 HE | Endure Biotherapeutics, Inc.
San Diego, Aug. 15, 2022 (GLOBE NEWSWIRE) --    FOR IMMEDIATE RELEASE Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics Zarrinpar...
Summit-logo-RGB.png
Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2022
11 août 2022 08h00 HE | Summit Therapeutics Inc.
Menlo Park, California, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on...
Summit-logo-RGB.png
Summit Therapeutics Closes Fully-Subscribed $100 Million Rights Offering
09 août 2022 13h37 HE | Summit Therapeutics Inc.
Menlo Park, California, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” "we," or the “Company”) today announced the successful closing of its fully-subscribed...